BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7075215)

  • 1. Forward on hemoperfusion and artificial cells.
    Chang TM
    Contrib Nephrol; 1982; 29():3-6. PubMed ID: 7075215
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemoperfusion in 1981.
    Chang TM
    Contrib Nephrol; 1982; 29():11-22. PubMed ID: 7042197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro assessment of charcoal and resin hemoadsorbents.
    Falkenhagen D; Gottschall S; Esther G; Courtney JM; Klinkmann H
    Contrib Nephrol; 1982; 29():23-33. PubMed ID: 7075214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe amitriptyline intoxication and the use of charcoal hemoperfusion.
    Comstock TJ; Watson WA; Jennison TA
    Clin Pharm; 1983; 2(1):85-8. PubMed ID: 6883936
    [No Abstract]   [Full Text] [Related]  

  • 5. [Resin hemoperfusion for acute pentobarbital intoxication in rats and rabbits].
    Lu ZN; Cai ZH; Wu ZG
    Zhongguo Yao Li Xue Bao; 1984 Dec; 5(4):281-5. PubMed ID: 6242224
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of resin hemoperfusion in the treatment of acute drug intoxication.
    Rosenbaum JL
    Clin Toxicol; 1972; 5(3):331-5. PubMed ID: 5073816
    [No Abstract]   [Full Text] [Related]  

  • 7. Present and future uses of hemoperfusion with sorbents.
    Winchester JF; Gelfand MC; Knepshield JH; Schreiner GE
    Artif Organs; 1978 Nov; 2(4):353-8. PubMed ID: 743004
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemoperfusion alone and in series with ultrafiltration or dialysis for uremia, poisoning and liver failure.
    Chang TM
    Kidney Int Suppl; 1976 Dec; (7):S305-11. PubMed ID: 1070552
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential for hemoperfusion in uremia.
    Winchester JF
    Contrib Nephrol; 1982; 29():114-22. PubMed ID: 6804166
    [No Abstract]   [Full Text] [Related]  

  • 10. Removal of alpha-amanitin from blood by hemoperfusion over uncoated charcoal. Experimental results.
    Masini E; Blandina P; Mannaioni PF
    Contrib Nephrol; 1982; 29():76-81. PubMed ID: 7075219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoperfusion: present and future.
    Gelfand MC
    J Dial; 1979; 3(1):1-9. PubMed ID: 469100
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of comatose patients by extracorporeal hemoperfusion with activated charcoal].
    Lie TS; Kim WI; Rommelsheim K; Holst A
    MMW Munch Med Wochenschr; 1976 Jul; 118(29-30):945-8. PubMed ID: 820984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of combined hemodialysis/hemoperfusion in chronic uremia.
    Stefoni S; Feliciangeli G; Colì L; Prandini R; Bonomini V
    Contrib Nephrol; 1982; 29():123-32. PubMed ID: 6804167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemoperfusion based on artificial cells for aluminium and iron removal, immunosorption, fulminant hepatic failure, uremia, poisoning and metabolic assists.
    Chang TM
    Int J Artif Organs; 1986 Sep; 9(5):285-8. PubMed ID: 3781657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoperfusion with gelatin-encapsulated charcoal.
    Wu ZG; Cai ZH; Lu ZN; Liao LT
    Chin Med J (Engl); 1984 Apr; 97(4):251-6. PubMed ID: 6434256
    [No Abstract]   [Full Text] [Related]  

  • 16. Medicoal (effervescent activated charcoal) in the treatment of acute poisoning.
    Drug Ther Bull; 1979 Jan; 17(2):7-8. PubMed ID: 759130
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemoperfusion with coated activated charcoal for treating acute poisoning by remedies, plant protectants, and fungi. III. Fungi (author's transl)].
    Okonek S
    Med Klin; 1977 Nov; 72(45):1917-21. PubMed ID: 927297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro adsorption of oxalic acid and glyoxylic acid onto activated charcoal, resins and hydrous zirconium oxide.
    Scholtens R; Scholten J; de Koning HW; Tijssen J; ten Hoopen HW; Olthuis FM; Feijen J
    Int J Artif Organs; 1982 Jan; 5(1):33-6. PubMed ID: 7068263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and selection of activated carbon for hemoperfusion.
    Walker JM; Denti E; Van Wagenen R; Andrade JD
    Kidney Int Suppl; 1976 Dec; (7):S320-7. PubMed ID: 1070555
    [No Abstract]   [Full Text] [Related]  

  • 20. Artificial cells in hemoperfusion and other applications.
    Chang TM
    Nephron; 1984; 36(3):161-8. PubMed ID: 6366599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.